NFATC2 explained

Nuclear factor of activated T-cells, cytoplasmic 2 is a protein that in humans is encoded by the NFATC2 gene.[1]

Function

This gene is a member of the nuclear factor of activated T cells (NFAT) family. The product of this gene is a DNA-binding protein with a REL-homology region (RHR) and an NFAT-homology region (NHR). This protein is present in the cytosol and only translocates to the nucleus upon T cell receptor (TCR) stimulation, where it becomes a member of the nuclear factors of activated T cells transcription complex. This complex plays a central role in inducing gene transcription during the immune response. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[2]

Clinical significance

Translocation forming an in frame fusions product between EWSR1 gene and the NFATc2 gene has been described in bone tumor with a Ewing sarcoma-like clinical appearance. The translocation breakpoint led to the loss of the controlling elements of the NFATc2 protein and the fusion of the N terminal region of the EWSR1 gene conferred constant activation of the protein.[3]

Interactions

NFATC2 has been shown to interact with MEF2D,[4] EP300,[5] IRF4[6] and Protein kinase Mζ.[7] Prostaglandin F2alpha stimulates a NFCT2 pathway stimulating growth of skeletal muscle cells.[8]

Further reading

Notes and References

  1. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR . NF-AT components define a family of transcription factors targeted in T-cell activation . Nature . 369 . 6480 . 497–502 . Jun 1994 . 8202141 . 10.1038/369497a0 . 1994Natur.369..497N . 9920546 .
  2. Web site: Entrez Gene: NFATC2 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2.
  3. Szuhai K, Ijszenga M, de Jong D, Karseladze A, Tanke HJ, Hogendoorn PC . The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology . Clinical Cancer Research . 15 . 7 . 2259–68 . Apr 2009 . 19318479 . 10.1158/1078-0432.CCR-08-2184 . free .
  4. Youn HD, Chatila TA, Liu JO . Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis . The EMBO Journal . 19 . 16 . 4323–31 . Aug 2000 . 10944115 . 302027 . 10.1093/emboj/19.16.4323 .
  5. García-Rodríguez C, Rao A . Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP) . The Journal of Experimental Medicine . 187 . 12 . 2031–6 . Jun 1998 . 9625762 . 2212364 . 10.1084/jem.187.12.2031 .
  6. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH . Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression . The Journal of Experimental Medicine . 195 . 8 . 1003–12 . Apr 2002 . 11956291 . 2193700 . 10.1084/jem.20011128 .
  7. San-Antonio B, Iñiguez MA, Fresno M . Protein kinase Czeta phosphorylates nuclear factor of activated T cells and regulates its transactivating activity . The Journal of Biological Chemistry . 277 . 30 . 27073–80 . Jul 2002 . 12021260 . 10.1074/jbc.M106983200 . free .
  8. Horsley V, Pavlath GK. Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. . J Cell Biol . 2003 . 161 . 1 . 111–8 . 12695501 . 10.1083/jcb.200208085 . 2172881 .